Skip to Main Content
  • Search by ticker
  • Sign up for emails
  • Contact Us
  • 866-476-7523
Leveraged & Inverse ETFs

Direxion Daily Pharmaceutical & Medical Bull 3X Shares

The Direxion Daily Pharmaceutical & Medical Bull 3X Shares seeks daily investment results, before fees and expenses, of 300% of the performance of the S&P Pharmaceuticals Select Industry Index. There is no guarantee the fund will achieve its stated investment objective.

PILL

NAV (Net Asset Value)$7.72As of Mar 18, 2024
1 Day NAV change$-0.18(-2.26%)As of Mar 18, 2024
Daily Target
+300%
Intra-day Value
PILL.IV
Daily NAV
$7.72
Daily Market Price
$7.75
Expense Ratio
(gross/net %)
1.13 / 1.00*
Daily Volume
139,146
Security Identifier
25460E646
Inception Date
Nov 15, 2017

Operational Updates

  • 01/23/2024
    Direxion's New ETF Alert Service. Get Price and Volume Alerts automatically via text message!
    Set Up Your ETF Alerts Today

Documents & Downloads

  • PILL Fact Sheet (pdf)
  • Direxion ETFs List (pdf)
  • Prospectus
  • Daily Fund Holdings (csv)

This leveraged ETF seeks a return that is 300% the return of its benchmark index for a single day. The fund should not be expected to provide three times the return of the benchmark’s cumulative return for periods greater than a day.

Pricing & Performance

NAV and Market Price information as of 03/18/2024.

PILL Direxion Daily Pharmaceutical & Medical Bull 3X Shares
Net Asset Value (NAV)
$7.72Nav
$-0.18Change
-2.26%Change
Market Price Closing
$7.75Market
$-0.15Change
-1.90%Change
Premium / Discount
$+0.03Change from Last Day Trading
Premium/Discount tool
Loading chart...
1M3MYTD1Y3Y5Y10YSince
Inception
Expense Ratio*
(Gross / Net%)
Inception
Date
PILL NAV
16.01
65.92
17.66
4.06
-29.70
-19.55
-14.41
1.13 / 1.00*
11/15/2017
PILL Market Close
16.24
65.79
17.29
4.96
-29.64
-19.49
-14.35
1.13 / 1.00*
11/15/2017

As of February 29, 2024

The Primary Listing Exchange is the NYSE Arca, Inc.

*The Net Expense Ratio includes management fees, other operating expenses and Acquired Fund Fees and Expenses. If Acquired Fund Fees and Expenses were excluded, the Net Expense Ratio would be 0.95%. The Fund’s adviser, Rafferty Asset Management, LLC (“Rafferty”) has entered into an Operating Expense Limitation Agreement with the Fund. Under the Operating Expense Limitation Agreement, Rafferty has contractually agreed to waive all or a portion of its management fee and/or reimburse the Fund for Other Expenses through September 1, 2024, to the extent that the Fund’s Total Annual Fund Operating Expenses exceed 0.95% of the Fund’s average daily net assets (excluding, as applicable, among other expenses, taxes, swap financing and related costs, acquired fund fees and expenses, dividends or interest on short positions, other interest expenses, brokerage commissions and extraordinary expenses). If these expenses were included, the expense ratio would be higher.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate. An investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted. Returns for performance under one year are cumulative, not annualized. For the most recent month-end performance please visit the funds website at direxion.com.

Short-term performance, in particular, is not a good indication of the fund’s future performance, and an investment should not be made based solely on returns. Because of ongoing market volatility, fund performance may be subject to substantial short-term changes. For additional information, see the fund’s prospectus.

Index Information

The S&P Pharmaceuticals Select Industry Index (SPSIPHTR) is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the Global Industry Classification Standard (GICS) pharmaceuticals sub-industry. One cannot invest directly in an index.

Index Top Ten Holdings

% of Total
Organon & Co
5.36%
Catalent Inc
4.95%
Intra-Cellular Therapies Inc
4.86%
Elanco Animal Health Inc
4.77%
Axsome Thera
4.64%
Viatris Inc
4.51%
Perrigo Co PLC
4.44%
Zoetis Inc
4.38%
Cymabay Therapeutics
4.35%
Merck & Co Inc
4.30%

Index Sector Weightings

% of Total
Pharmaceuticals
100.00%
Index data as of 12/31/2023. Index sector weightings and top holdings are subject to change.

View Daily Fund Holdings

Strategy & Benefits

You know that TRADING is different than investing. But the opportunity to take advantage of short-term trends is only won, if you get the direction right.

Whether you’re a bull or a bear, Direxion is with you. Our leveraged ETFs are powerful tools built to help you:

  • Magnify your short-term perspective with daily 3X leverage
  • Go where there’s opportunity, with bull and bear funds for both sides of the trade; and
  • Stay agile – with liquidity to trade through rapidly changing markets

Leveraged and inverse ETFs pursue daily leveraged investment objectives which means they are riskier than alternatives which do not use leverage. They seek daily goals and should not be expected to track the underlying index over periods longer than one day. They are not suitable for all investors and should be utilized only by investors who understand leverage risk and who actively manage their investments.

Distributions

Record DateEx DatePay DateIncome DividendShort-Term Capital GainLong-Term Capital GainReturn of Capital
12/22/202312/21/202312/29/20230.03825
09/20/202309/19/202309/26/20230.03531
06/22/202306/21/202306/28/20230.04923
03/22/202303/21/202303/28/20230.01911
12/21/202212/20/202212/28/20220.03171
09/21/202209/20/202209/27/20220.01673
06/23/202206/22/202206/29/20220.00361
03/23/202203/22/202203/29/20220.00817
12/22/202112/21/202112/29/20210.00007
12/24/201912/23/201912/31/20190.00033
09/25/201909/24/201910/01/20190.014430.00078
06/26/201906/25/201907/02/20190.021220.00115
03/20/201903/19/201903/26/20190.054390.00294
12/28/201812/27/201801/04/20190.09858
09/26/201809/25/201810/02/20180.04338
06/20/201806/19/201806/26/20180.05228
12/20/201712/19/201712/27/20170.01351
Record Date12/22/2023
Ex Date12/21/2023
Pay Date12/29/2023
Income Dividend0.03825
Short-Term Capital Gain
Long-Term Capital Gain
Return of Capital
Record Date09/20/2023
Ex Date09/19/2023
Pay Date09/26/2023
Income Dividend0.03531
Short-Term Capital Gain
Long-Term Capital Gain
Return of Capital
Record Date06/22/2023
Ex Date06/21/2023
Pay Date06/28/2023
Income Dividend0.04923
Short-Term Capital Gain
Long-Term Capital Gain
Return of Capital
Record Date03/22/2023
Ex Date03/21/2023
Pay Date03/28/2023
Income Dividend0.01911
Short-Term Capital Gain
Long-Term Capital Gain
Return of Capital
Record Date12/21/2022
Ex Date12/20/2022
Pay Date12/28/2022
Income Dividend0.03171
Short-Term Capital Gain
Long-Term Capital Gain
Return of Capital
Record Date09/21/2022
Ex Date09/20/2022
Pay Date09/27/2022
Income Dividend0.01673
Short-Term Capital Gain
Long-Term Capital Gain
Return of Capital
Record Date06/23/2022
Ex Date06/22/2022
Pay Date06/29/2022
Income Dividend0.00361
Short-Term Capital Gain
Long-Term Capital Gain
Return of Capital
Record Date03/23/2022
Ex Date03/22/2022
Pay Date03/29/2022
Income Dividend0.00817
Short-Term Capital Gain
Long-Term Capital Gain
Return of Capital
Record Date12/22/2021
Ex Date12/21/2021
Pay Date12/29/2021
Income Dividend0.00007
Short-Term Capital Gain
Long-Term Capital Gain
Return of Capital
Record Date12/24/2019
Ex Date12/23/2019
Pay Date12/31/2019
Income Dividend0.00033
Short-Term Capital Gain
Long-Term Capital Gain
Return of Capital
Record Date09/25/2019
Ex Date09/24/2019
Pay Date10/01/2019
Income Dividend0.01443
Short-Term Capital Gain
Long-Term Capital Gain
Return of Capital0.00078
Record Date06/26/2019
Ex Date06/25/2019
Pay Date07/02/2019
Income Dividend0.02122
Short-Term Capital Gain
Long-Term Capital Gain
Return of Capital0.00115
Record Date03/20/2019
Ex Date03/19/2019
Pay Date03/26/2019
Income Dividend0.05439
Short-Term Capital Gain
Long-Term Capital Gain
Return of Capital0.00294
Record Date12/28/2018
Ex Date12/27/2018
Pay Date01/04/2019
Income Dividend0.09858
Short-Term Capital Gain
Long-Term Capital Gain
Return of Capital
Record Date09/26/2018
Ex Date09/25/2018
Pay Date10/02/2018
Income Dividend0.04338
Short-Term Capital Gain
Long-Term Capital Gain
Return of Capital
Record Date06/20/2018
Ex Date06/19/2018
Pay Date06/26/2018
Income Dividend0.05228
Short-Term Capital Gain
Long-Term Capital Gain
Return of Capital
Record Date12/20/2017
Ex Date12/19/2017
Pay Date12/27/2017
Income Dividend0.01351
Short-Term Capital Gain
Long-Term Capital Gain
Return of Capital

Documents

Tax Documents

Download the following Tax Reporting Documents

How to Buy

ETFs are generally available for purchase on exchanges, much like stocks—and can be bought and sold throughout the trading day whenever exchanges are open. Direxion ETFs cannot be purchased directly from Direxion, but are available for trading on most trading platforms.

We strongly recommend that you take the time to educate yourself on how leveraged and inverse ETFs function and behave in various market conditions before you endeavor to trade them in your account. It’s always a good idea to consult a financial advisor or brokerage account representative if you have questions about any ETFs.

Please note, your advisor or broker may charge commissions or other transaction fees.If you have any questions specific to Direxion products, please contact us direct at [email protected] or 866-476-7523.

Operational Updates

Documents & Downloads

How to Buy

While you can't purchase our funds from our website, investors still have multiple options for buying Direxion ETFs
Learn more about buying Direxion ETFs

Browse Other Funds

View more of our Leveraged & Inverse ETFs at Direxion. As of March 18, 2024
View All

Subscribe to Newsletters & Operational Updates

Sign up for email and/or text of the important news, including:

  • Fund updates including splits, distributions, launches, and other corporate actions
  • Educational events, such as web seminars and conferences
  • Our latest research and industry trends
Subscribe

Learn About Leveraged & Inverse ETFs

Trading is different than investing. Use our insights and educational resources to make sure you’re ready to trade in Direxion’s Leveraged and Inverse ETFs.

an illustration of a book with a graduate cap on to represent the Direxion University

Leveraged and Inverse ETF Education Center

Educational materials, videos, and self-paced online training.

illustration of an 'X' with candlestick chart elements over the top

The Xchange Newsletter

Leveraged ETF market trends and trading ideas. Read our latest article and subscribe.

an illustration of a video for Leveraged & Inverse ETF Education

Leveraged & Inverse ETF Videos

Short videos to teach you about our Leveraged & Inverse ETFs.